GRCE

Grace Therapeutics
GRCE

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $205K invested in Grace Therapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$43.9K
2
+$25.6K
3
+$15K
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
+$1.15K
5
UBS Group
UBS Group
Switzerland
+$1K

Top Sellers

1
-$88K
2
-$23K
3
-$19K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$69K
2
$66K
3
$22K
4
$22K
5
$15K
6
$6K
7
$2.44K
8
$1K
9
$1K
10
$276
11
–
12
–
13
–